Want to see SPNT full AI Analyst Report?
Top Page
SiriusPoint
(NYSE:SPNT)
Select Model
Select Model
Rating:73Outperform
Price Target:
$26.00
▲(11.68% Upside)
Action:Reiterated
Date:06/01/26
SPNT scores well on fundamentals and narrative: improved profitability/ROE with manageable leverage, plus a positive earnings update emphasizing underwriting discipline, capital strength, and increased buybacks. The biggest offset is weak near-term technical momentum (below key moving averages with bearish indicators), despite an attractive low P/E valuation.
Positive Factors
Underwriting discipline & profitability
Sustained underwriting profitability and a sub-90% core combined ratio reflect disciplined pricing and loss control. Over a 2–6 month horizon this reduces earnings volatility, supports reserve strengthening and underpins targeted ROE levels, improving franchise stability through cycles.
Negative Factors
Top-line volatility & reinsurance shrinkage
Deliberate pullback in reinsurance and one‑off impacts leave top-line growth uneven. Over the medium term, a smaller reinsurance footprint and reliance on insurance segment growth can constrain diversification and premium scale, making revenues more sensitive to line‑specific cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
Underwriting discipline & profitability
Sustained underwriting profitability and a sub-90% core combined ratio reflect disciplined pricing and loss control. Over a 2–6 month horizon this reduces earnings volatility, supports reserve strengthening and underpins targeted ROE levels, improving franchise stability through cycles.
Read all positive factors
SiriusPoint (SPNT) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$2.90B
Dividend YieldN/A
Average Volume (3M)805.60K
Price to Earnings (P/E)6.1
Beta (1Y)0.29
Revenue Growth22.94%
EPS Growth317.95%
CountryUS
Employees1,068
SectorFinancial
Sector Strength70
IndustryInsurance - Reinsurance
Share Statistics
EPS (TTM)4.07
Shares Outstanding117,542,130
10 Day Avg. Volume830,209
30 Day Avg. Volume805,595
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.03
Price to Sales (P/S)0.80
P/FCF Ratio24.91
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue0.74
Enterprise Value/Gross Profit1.63
Enterprise Value/Ebitda3.55
Forecast
1Y Price Target
$28.00Price Target Upside20.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)2.56
Revenue Forecast (FY)$3.32B
SiriusPoint Business Overview & Revenue Model
Company Description
SiriusPoint Ltd. provides multi-line reinsurance and insurance products and services worldwide. It operates in four segments: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty. Global P&C Programs segme...
How the Company Makes Money
SiriusPoint primarily makes money through (1) underwriting income and (2) investment income on its invested assets, with additional contributions from fee-based or other income where applicable.
1) Underwriting income (core operating revenue)
- P...
SiriusPoint Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Positive
Overall the call conveyed strong operational and capital progress — improved underwriting margins, multi-quarter underwriting profitability, ROE above targets, meaningful capital returns and rating upgrades. Headwinds are present in reinsurance/pricing in certain niche markets, elevated short-term expenses and some one-off premium effects, but management emphasizes disciplined underwriting, reduced catastrophe exposure, prudent reserving and a strong balance sheet. The positives on profitability, capital strength and reserve releases materially outweigh the noted market and line-specific challenges.Positive Updates
Improved Underwriting Performance
Core combined ratio improved to 88.9% (lowest in 6 quarters) and underwriting income was $71 million, a 149% year-over-year increase; this marks the 14th consecutive quarter of underwriting profitability.
Negative Updates
Reinsurance and Net Written Premium Declines
Reinsurance gross written premium declined 10% year-over-year (management remained disciplined in property catastrophe); net written premium declined 7% driven by preannounced aggregate cover and a one-time prior-year Surety item.
Read all updates
Q1-2026 Updates
Positive
Negative
Improved Underwriting Performance
Core combined ratio improved to 88.9% (lowest in 6 quarters) and underwriting income was $71 million, a 149% year-over-year increase; this marks the 14th consecutive quarter of underwriting profitability.
Read all positive updates
Company Guidance
Management guided full‑year gross written premium growth of 5%–10%, with Insurance & Services expected to deliver strong, double‑digit growth and a mix shift that will weight growth to the second half; other underwriting expenses were reaffirmed at 6.5%–7% for the year. Q1 set a strong baseline—core combined ratio 88.9% with $71m of underwriting income (14th consecutive profitable quarter), GWP $1.0bn (+1% YoY; adjusted GWP/NWP ~+4% ex one‑offs), net earned premium +2%, net written premium -7% (impacted by aggregate cover and a one‑time prior‑year item), operating net income $86m ($0.70/share), operating ROE 15.3% (core operating ROE 17.9%, GAAP ROE 17.4%). Capital and liquidity guidance/positioning highlighted a BSCR of 242%, leverage ~22.8%–23%, >$240m of capital returned YTD (including $200m preference redemption and >$40m common buybacks), the buyback increased to a $174m pre‑authorization (additional $74m), book value per diluted share excl. AOCI $18.98 (+5% sequentially); investments produced $66m net investment income and $78m total investment result (fixed income avg. credit AA‑, duration 3.1 yrs, reinvestment yields >4.5%); reserving remains prudent with favorable PYD ($32m core, $18m consolidated, 20 consecutive quarters) and runoff reserves under $500m (down from >$1bn end‑2023, ~90% reported by mid‑2027).SiriusPoint Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
76
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.23B | 3.21B | 2.61B | 2.70B | 2.17B | 2.22B |
| Gross Profit | 1.47B | 1.69B | 728.40M | 848.40M | 121.30M | 510.40M |
| EBITDA | 676.50M | 622.50M | 314.60M | 393.90M | -376.00M | 85.00M |
| Net Income | 500.20M | 459.60M | 199.90M | 354.80M | -386.80M | 58.10M |
Balance Sheet | ||||||
| Total Assets | 12.48B | 12.57B | 12.52B | 12.87B | 11.04B | 10.62B |
| Cash, Cash Equivalents and Short-Term Investments | 3.24B | 3.35B | 3.81B | 3.69B | 4.33B | 2.08B |
| Total Debt | 679.60M | 688.60M | 639.10M | 786.20M | 778.00M | 816.70M |
| Total Liabilities | 10.18B | 10.10B | 10.59B | 10.34B | 8.95B | 8.12B |
| Stockholders Equity | 2.30B | 2.47B | 1.94B | 2.51B | 2.07B | 2.50B |
Cash Flow | ||||||
| Free Cash Flow | 330.80M | 102.40M | 74.70M | 581.30M | 292.50M | 1.60M |
| Operating Cash Flow | 330.80M | 102.40M | 74.70M | 581.30M | 293.30M | 1.60M |
| Investing Cash Flow | 2.10M | 424.20M | 343.60M | -332.20M | -1.30B | 208.60M |
| Financing Cash Flow | -249.20M | -518.80M | -625.00M | -61.50M | -23.70M | 24.30M |
SiriusPoint Technical Analysis
Positive
23.28
Price Trends
22.99
Positive
22.19
Positive
21.02
Positive
Market Momentum
0.41
Negative
64.91
Neutral
79.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SPNT, the sentiment is Positive. The current price of 23.28 is above the 20-day moving average (MA) of 23.12, above the 50-day MA of 22.99, and above the 200-day MA of 21.02, indicating a bullish trend. The MACD of 0.41 indicates Negative momentum. The RSI at 64.91 is Neutral, neither overbought nor oversold. The STOCH value of 79.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SPNT.
SiriusPoint Risk Analysis
SiriusPoint disclosed 62 risk factors in its most recent earnings report. SiriusPoint reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
SiriusPoint Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $3.42B | 5.48 | 23.38% | ― | 20.32% | 98.92% | |
74 Outperform | $13.91B | 5.43 | 24.71% | 0.57% | -8.19% | 90.81% | |
73 Outperform | $2.90B | 6.05 | 22.02% | ― | 22.94% | 317.95% | |
73 Outperform | $14.48B | 11.83 | 9.47% | 1.76% | 18.66% | 55.67% | |
72 Outperform | $542.93M | 6.82 | 11.68% | ― | 0.10% | 77.35% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
56 Neutral | $10.37M | -5.00 | -50.32% | ― | 84.01% | 19.53% |
* Financial Sector Average
SPNT
SiriusPoint
24.63
4.83
24.39%
GLRE
Greenlight Capital Re
16.37
2.05
14.32%
RGA
Reinsurance Group
221.00
25.99
13.33%
RNR
Renaissancere Holdings
326.29
86.80
36.24%
OXBR
Oxbridge Re Holdings
1.28
-0.88
-40.74%
HG
Hamilton Insurance Group, Ltd. Class B
34.44
14.45
72.29%
SiriusPoint Corporate Events
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
SiriusPoint Shareholders Approve Directors, Pay and SharePlan
Positive
May 21, 2026
On May 20, 2026, SiriusPoint Ltd. held its 2026 annual general meeting of shareholders, where investors elected two Class I directors, Susan L. Cross and Sabra R. Purtill, to serve until the 2029 annual meeting, reinforcing continuity and stabilit...
Business Operations and StrategyStock BuybackFinancial Disclosures
SiriusPoint Delivers Strong Q1 2026 Results, Boosts Buybacks
Positive
May 7, 2026
SiriusPoint reported strong first-quarter 2026 results on May 7, 2026, posting net income of $100 million, or $0.82 per diluted share, and operating earnings per share of $0.70, up 37% year on year. The group delivered a 17.4% annualized return on...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.